Blog
About

15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth.

      The Journal of Biological Chemistry

      Tumor Cells, Cultured, Time Factors, Signal Transduction, metabolism, Ribonucleases, Receptor Protein-Tyrosine Kinases, RNA, Messenger, RNA, Catalytic, Protein-Tyrosine Kinases, Phosphorylation, Neoplasm Transplantation, Mitosis, Mice, Nude, Mice, Kinetics, In Situ Nick-End Labeling, In Situ Hybridization, Immunohistochemistry, Humans, Glioblastoma, Cytokines, Cell Division, Carrier Proteins, Brain Neoplasms, embryology, Brain, Blotting, Western, Apoptosis, Animals

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Glioblastoma multiforme is the most common highly aggressive human brain cancer, and receptor tyrosine kinases have been implicated in the progression of this malignancy. We have recently identified anaplastic lymphoma kinase (ALK) as a tyrosine kinase receptor for pleiotrophin, a secreted growth factor that is highly expressed during embryonic brain development and in tumors of the central nervous system. Here we report on the contribution of pleiotrophin-ALK signaling to glioblastoma growth. We found ALK overexpressed in human glioblastoma relative to normal brain and detected ALK mRNA in glioblastoma cell lines. We reduced the endogenous ALK in glioblastoma cells by ribozyme targeting and demonstrated that this prevents pleiotrophin-stimulated phosphorylation of the anti-apoptotic protein Akt. Furthermore, this depletion of ALK reduced tumor growth of xenografts in athymic nude mice and prolonged survival of the animals because of increased apoptosis in the tumors. These findings directly implicate ALK signaling as a rate-limiting factor in the growth of glioblastoma multiforme and suggest potential utility of therapeutic targeting of ALK.

          Related collections

          Author and article information

          Journal
          10.1074/jbc.M112354200
          11809760

          Comments

          Comment on this article